The going-concern warning and stalled Nanox.ARC deployments are the dominant signals. Despite revenue growth from teleradiology and Health IT, the core hardware business is not scaling, and cash runway is tight even after the $8.5M raise. Monitor for further dilutive financing, potential asset sales, or a reverse stock split to maintain Nasdaq listing. The class action adds legal overhang. Short-term trading will likely focus on liquidity runway and any new deployment announcements.
Price Chart
Executive Summary
Nanox reported Q2 2026 revenue of $4.2M (+37% YoY), but GAAP net loss widened to $55.5M from $14.7M due to a $40.7M non-cash impairment of AI Solutions intangible assets. The company disclosed substantial doubt about its ability to continue as a going concern, with cash burn of $25.5M in H1 2026 and only $31.4M in cash at quarter-end, partially offset by $8.5M in post-quarter capital raises. While teleradiology and Nanox Health IT revenue grew, the core Nanox.ARC system deployments have stalled, and the Korea restructuring signals a strategic retreat from in-house manufacturing.
Key Facts
- Q2 2026 revenue was $4.2M, up 37% YoY from $3.0M, driven by consolidation of Nanox Health IT ($0.9M contribution).
- GAAP net loss was $55.5M in Q2 2026 vs $14.7M in Q2 2025, including a $40.7M impairment of AI Solutions intangible assets.
- Non-GAAP net loss was $11.6M in Q2 2026 vs $10.9M in Q2 2025; adjusted EBITDA loss was $11.3M vs $10.4M.
- Cash and cash equivalents fell to $31.4M at June 30, 2026 from $49.2M at Dec 31, 2025; net cash used in operations was $25.5M in H1 2026.
- Management expressed substantial doubt about going concern, stating cash is insufficient for 12 months of operations.
- Post-quarter, the company raised $8.5M gross via a registered direct offering (3.7M shares + 4.3M pre-funded warrants + 8M warrants) and ATM sales.
- A $40.7M impairment was recorded on AI Solutions intangible assets (excluding Nanox Health IT), reducing their fair value to $1.9M.
- Korea restructuring includes 67% headcount reduction, transitioning chip manufacturing to third parties, with ~$0.9M in charges and expected $2M annual savings from 2027.
- There has been no material change in the number of Nanox.ARC systems deployed from previously reported levels.
- A securities class action was filed on June 12, 2026, alleging misrepresentations about the Korea manufacturing facility; no accrual recorded.
- Shareholders' equity dropped to $72.5M from $139.7M at Dec 31, 2025, driven by the net loss and impairment.
- Gross loss margin was -1,051% on a GAAP basis and -13% on a non-GAAP basis in Q2 2026.
Financial Impact
Q2 2026 GAAP net loss of $55.5M, including $40.7M non-cash impairment; cash burn of $25.5M in H1 2026; post-quarter capital raises of $8.5M gross
Risk Factors
- Going-concern risk: cash may be insufficient for 12 months of operations without additional financing.
- Dilution risk: post-quarter offering added 3.7M shares + 4.3M pre-funded warrants + 8M warrants; further capital raises likely.
- Commercialization risk: no material increase in Nanox.ARC deployments; pay-per-scan model not gaining traction.
- Legal risk: securities class action could result in material damages if the case proceeds.
- Execution risk: Korea restructuring may disrupt supply chain and delay any future system deployments.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-098227 |
| Document: ea030482601ex99-1.htm | 0001213900-26-098227 |
| Document: ea030482601ex99-3.htm | 0001213900-26-098227 |
| Document: ea0304826-6k_nanox.htm | 0001213900-26-098227 |
| Document: 0001213900-26-098227-index-headers.html | 0001213900-26-098227 |
| Document: 0001213900-26-098227-index.html | 0001213900-26-098227 |
| Document: 0001213900-26-098227.txt | 0001213900-26-098227 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 6-K | $0.4100 | awaiting T+20 | — | $0.3430 (+16.34%) |
Oct 16, 2026 10d ago | Press Release | $0.4100 | awaiting T+20 | — | $0.3430 (+16.34%) |
Oct 2, 2026 24d ago | 6-K | $0.6430 | awaiting T+20 | — | $0.3430 (+46.66%) |
Sep 9, 2026 6w ago | 6-K | $0.7800 $0.5950 | ▲ +23.72% | ▲ +25.66% | $0.3430 (+56.03%) |
Aug 18, 2026 9w ago | Press Release | $0.8869 $0.7537 | ▼ −15.02% | ▼ −13.27% | $0.3430 (−61.33%) |
Aug 18, 2026 9w ago | 6-K | $0.8869 $0.7537 | ▲ +15.02% | ▲ +13.27% | $0.3430 (+61.33%) |
Aug 7, 2026 11w ago | 424B5 | $1.06 $0.8298 | ▲ +21.72% | ▲ +21.32% | $0.3430 (+67.64%) |
Aug 4, 2026 11w ago | 144 | $1.07 $0.7859 | ▼ −26.55% | ▼ −25.31% | $0.3430 (−67.94%) |
Jul 28, 2026 12w ago | 144 | $0.8772 $0.8758 | ▲ +0.16% | ▲ +5.18% | $0.3430 (+60.90%) |
Jul 23, 2026 13w ago | 6-K | $0.8962 $0.8599 | ▲ +4.05% | ▲ +7.68% | $0.3430 (+61.73%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers